EUROPEAN CLUSTER FOR IMAGING BIOMARKERS CLUSTER
The European Cluster for Imaging Biomarkers (ECIB) forges a complementary and synergetic harmonization alliance across major European consortia, networks and platforms engaged in multicentric collection, curation, transfer, and analysis of “big-imaging-data”. Our ambition is to achieve transformative leaps in the translation of “big-imaging-data”-research into scientific and medical innovations by creating critical synergies between neuroimaging projects at both European and global level. In the big picture, we aspire to become instrumental in unlocking the full potential of new tools, technologies, and digital solutions for a healthy society.
Cluster description
We have formed a highly inclusive Cluster of “big-imaging-data” projects from JPND, Horizon2020, and IMI. These projects are supplemented by National Neuroimaging Platforms of France, Italy and Germany and one of the largest national multicentric imaging biomarker consortium, the Swedish BioFINDER Study. This Cluster will weave together large European projects of different entities (Consortia, Networks, and Platforms) for a common greater goal: deploying latest advances in data science, computing, and imaging technologies to develop imaging biomarkers supporting personalized diagnostics and treatments in brain disorders.
Our goal within the EBRA activities is a structured examination and recording of: viewpoints, positions and approaches with regard to chances, challenges and limitations on sharing brain imaging data in online data repositories, particularly considering open access under the requirements of EU data protection laws from an investigator’s perspective.
To address this critical need, we have formed a highly inclusive Cluster of “big-imaging-data” projects across funding programs such as Horizon, JPND, ERA-Net NEURON and IMI. These projects are supplemented by National Neuroimaging Platforms of France, Italy, Germany and Sweden. This Cluster will weave together large European projects of different entities (Consortia, Networks, and Platforms) for a common greater goal: deploying latest advances in data science, computing, and imaging technologies to develop imaging biomarkers supporting personalized diagnostics and treatments in brain disorders.